Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Artemisia rupestris extract is a traditional herbal medicine derived from Artemisia rupestris L., a perennial herb widely distributed in Xinjiang (China), Central Asia, and Europe[4]. It is used in traditional medicine for its antiallergic, antibacterial, and antiviral effects[4]. The main bioactive components are polysaccharides (notably water-extractable polysaccharides), flavonoids (such as artemetin, chrysosplenetin, pachypodol, penduletin, chrysoeriol), and other phytochemicals[1][2][4]. The extract has demonstrated immunomodulatory, antimicrobial, and adjuvant activities in preclinical studies[1][2][4]. It is not currently a registered pharmaceutical drug but is of research interest as a potential adjuvant and for its broad-spectrum bioactivities.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on artemisia rupestris extract.